1-2 of 2
Samuel Romero, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Infection Risk in Lymphoproliferative Diseases (LPD) Treated with Targeted Drugs. Geltamo Real-Life Experience

Maria Stefania Infante, MD, Ana Fernandez-Cruz, MD, Lucia Nuñez, Cecilia Carpio, MD, Ana Jimenez-Ubieto, Javier Lopez Jimenez, MD PhD, Lourdes Vázquez, MD, Raquel Del Campo, Samuel Romero, MD, Carmen Alonso Prieto, Daniel Murillo, Margarita Prat, Jose Luis Plana Cuenca, Paola Villaverde Gutiérrez, Gabriela Bastidas, MD, Ana Bocanegra, Ángel Serna, MD, Rodrigo de Nicolas, Juan Marquet Palomanes, Julio Garcia-Suarez, Maria Carmen Mas Ochoa, Alessandra Comai, MD, Xabier Martin, Cristina Seri, MD, Belen Navarro Matilla, Jose Angel Hernandez-Rivas, MD PhD, Armando Lopez-Guillermo, Isabel Ruiz-Campos, Carlos Grande
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–40.
https://doi.org/10.1182/blood-2020-134729
Published: 2020
Journal Articles

Idelalisib for Relapsed/Refractory Follicular Lymphoma: Retrospective Study from Spanish Lymphoma Group Geltamo (GELT-IDE-2018-02)

Juan-Manuel Sancho, MD PhD, Olga García, Pablo Mozas, Santiago Mercadal, MD, Eva Donato, MD, Ana Muntañola Prat, MD, Javier Lopez Jimenez, MD, Pascual Fernandez Abellan, PhD, Jose-Angel Hernandez, MD, Maria J. Rodriguez-Salazar, MD, Samuel Romero, MD, Ana Marin Niebla, PhD, Angel Ramirez Payer, Raul Cordoba, MD PhD, Jose Luis Bello, MD, Beatriz Cuevas, MD, Itziar Oiartzabal, MD, Alejandro Martín, MD PhD, Jose Javier Sanchez Blanco, Nicholas Kelleher, MD, Ana Lafuente, MD, Marc Sorigué, MD, López Guillermo Armando, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5249.
https://doi.org/10.1182/blood-2019-125921
Published: 2019